AMES, Iowa – Laboratory video tells the story: tiny, parasitic worms swimming freely in a nutrient solution are active and mobile; expose the same kind of worms to a mixture of four drugs optimized by ...

The use of artificial intelligence in drug discovery, when coupled with new genetic insights and the increase of patient medical data of the last decade, has the potential to bring novel medicines to ...

Neurodegenerative diseases such as Alzheimer’s disease (AD), Parkinson’s disease (PD), motor neuron disease (MND, including amyotrophic lateral sclerosis, (ALS)), and frontotemporal dementia (FTD) ...

(BOSTON) - A new strategy for engineering protein fusions -- to make specific cell-targeted drugs without side effects -- could enable a safer, more potent class of protein drugs. A team at the Wyss ...

When disease outbreaks happen, response time in developing and distributing treatments is crucial to saving lives. Unfortunately, developing custom drugs as countermeasures is often a slow and ...

SAN DIEGO--(BUSINESS WIRE)--Ablexis, LLC (“Ablexis”), a biopharmaceutical company focused on licensing its AlivaMab ® Mouse technology for antibody drug discovery, and AlivaMab Discovery Services, LLC ...

Every graduate student, creative person and inventor of any stripe has experienced periods when nothing seems to come together, some of us many times. I was waist-deep in such pit after a year-long ...

A pioneer in the engineering of polymers for drug-delivery applications to treat diseases such as cancer and mental illness, Dr. Robert Langer has been awarded the 2015 Queen Elizabeth Prize for ...

Fail fast, fail cheap is a common clich in drug development. Studies project that anywhere from 4060% of potential drugs candidates fail in development due to absorption, distribution, metabolism, ...

Dr. Kidochukwu Atube is among a rising group of Nigerian scientists whose work spans engineering, pharmaceutical sciences and immunology, earning him growing international recognition. Recent ...